United StatesÚltimas notícias

Delaware Life has added Bitcoin-linked exposure to its retirement annuity portfolio via a BlackRock-developed index.

Coinbase says wealth creation increasingly depends on access to capital markets rather than income or traditional banking.

WLFI is under fire after team wallets pushed through a USD1 proposal while many locked holders were unable to vote.

European regulators in Hungary and Portugal have taken steps to block Polymarket, intensifying scrutiny of crypto prediction markets.

Messari warns that without KYC checks, insider trading on prediction markets is extremely difficult to prevent.

Japan’s bond market has been sliding all week, with the 10-year yield now near 2.37% and the 40-year pushing above 4.2%, both multi-decade highs.

Bristol Myers Squibb (NYSE:BMY) has partnered with Microsoft (NASDAQ:MSFT) to deploy artificial intelligence tools aimed at identifying lung cancer in its earliest stages, marking the latest push by a pharmaceutical giant to integrate big tech’s machine learning into clinical care.

D.R. Horton (NYSE:DHI) reported first-quarter results that surpassed Wall Street expectations on Tuesday, even as the nation's largest homebuilder grapples with a persistent "wait-and-see" attitude from buyers.

United Airlines Holdings (NYSE:UAL) shares took flight in after-hours trading Tuesday after the carrier posted the highest quarterly revenue in its history, overcoming a costly government shutdown to deliver a significant earnings beat.

Netflix (NASDAQ:NFLX) shares dipped in after-hours trading Tuesday despite the streaming giant beating revenue expectations and crossing the 325-million subscriber milestone, as investors weighed the massive financial commitments of its pending Warner Bros. Discovery acquisition.

A broad selloff erased billions in market value Tuesday as investors retreated from high-flying technology stocks, spooked by President Trump’s escalating trade war threats against European allies.

Corvus Pharmaceuticals (NASDAQ:CRVS) shares skyrocketed more than 60% in early trading Tuesday after the company reported that its experimental oral therapy significantly cleared skin in patients with moderate-to-severe atopic dermatitis.